abstract |
(57) [Summary] [Object] According to the present invention, a bispecific antibody effective for treating cancer is provided. [Structure] A bispecific antibody comprising an anti-sialyl Lewis A monoclonal antibody and an anti-CD3 monoclonal antibody, which is reactive with sialyl Lewis A antigen and CD3. |